{
    "clinical_study": {
        "@rank": "106076", 
        "arm_group": [
            {
                "arm_group_label": "ACA-doxy 14 days", 
                "arm_group_type": "Active Comparator", 
                "description": "patients with chronic atrophic acrodermatitis treated with doxycycline for 14 days"
            }, 
            {
                "arm_group_label": "ACA-doxy 28 days", 
                "arm_group_type": "Active Comparator", 
                "description": "patients with chronic atrophic acrodermatitis treated with doxycycline for 28 days"
            }
        ], 
        "brief_summary": {
            "textblock": "The main objective of this study is to characterize the inflammatory proteins, gene\n      polymorphisms, and transcriptome profiles in patients with chronic atrophic dermatitis to\n      gain better insight into pathogenesis of chronic infection with Borrelia burgdorferi sensu\n      lato."
        }, 
        "brief_title": "Laboratory Characteristics in Chronic Atrophic Acrodermatitis", 
        "condition": "Chronic Atrophic Acrodermatitis", 
        "condition_browse": {
            "mesh_term": [
                "Acrodermatitis", 
                "Atrophy"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  chronic atrophic dermatitis in patients >18 years\n\n        Exclusion Criteria:\n\n          -  none"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02147262", 
            "org_study_id": "ACA-0613"
        }, 
        "intervention": [
            {
                "arm_group_label": "ACA-doxy 14 days", 
                "intervention_name": "doxycycline orally, 100 mg, bid, 14 days", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "ACA-doxy 28 days", 
                "intervention_name": "doxycycline orally, 100 mg, bid, 28 days", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Doxycycline", 
                "Doxycycline hyclate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "chronic atrophic acrodermatitis", 
            "Lyme borreliosis", 
            "molecular characteristics", 
            "outcome"
        ], 
        "lastchanged_date": "May 23, 2014", 
        "location": {
            "contact": {
                "email": "cerar.dasa@gmail.com", 
                "last_name": "Dasa Stupica, MD,PhD", 
                "phone": "+386 1 522 2110"
            }, 
            "contact_backup": {
                "email": "franc.strle@kclj.si", 
                "last_name": "Franc Strle, MD,PhD", 
                "phone": "+386 1 522 2610"
            }, 
            "facility": {
                "address": {
                    "city": "Ljubljana", 
                    "country": "Slovenia", 
                    "zip": "1525"
                }, 
                "name": "UMC Ljubljana, Department of Infectious Diseases"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Slovenia"
        }, 
        "number_of_arms": "2", 
        "official_title": "Inflammatory Proteins,Gene Polymorphisms, and Transcriptome Profiles in Patients With Chronic Atrophic Acrodermatitis", 
        "other_outcome": [
            {
                "description": "The expression of disease-relevant genomic variants will be assessed using ImmunoChip.", 
                "measure": "gene polymorphisms in patients with chronic atrophic dermatitis", 
                "safety_issue": "No", 
                "time_frame": "at enrollment, at 6 months follow-up"
            }, 
            {
                "description": "We will use RNA sequencing of individual immune cell subtypes from patients to determine their transcriptome.", 
                "measure": "transcriptome profiles in patients with chronic atrophic dermatitis", 
                "safety_issue": "No", 
                "time_frame": "at enrollment"
            }
        ], 
        "overall_contact": {
            "email": "cerar.dasa@gmail.com", 
            "last_name": "Dasa Stupica, MD, PhD", 
            "phone": "+386 1 522 2110"
        }, 
        "overall_contact_backup": {
            "email": "franc.strle@kclj.si", 
            "last_name": "Franc Strle, MD, PhD", 
            "phone": "+386 1 522 2610"
        }, 
        "overall_official": [
            {
                "affiliation": "UMC Ljubljana", 
                "last_name": "Franc Strle, MD, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "UMC Ljubljana", 
                "last_name": "Dasa Stupica, MD, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Slovenia: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The inflammatory immune profiles will be assessed using Luminex to measure the expression of cytokines and chemokines representative of innate and adaptive TH1, TH2, TH17, and B cell responses.", 
            "measure": "inflammatory proteins in patients with chronic atrophic dermatitis", 
            "safety_issue": "No", 
            "time_frame": "up to  24 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02147262"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Medical Centre Ljubljana", 
            "investigator_full_name": "Franc Strle", 
            "investigator_title": "M.D., PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "clinical characteristics of patients with chronic atrophic dermatitis treated with doxycycline for 14 or 28 days", 
            "safety_issue": "No", 
            "time_frame": "at enrollment, at 2, 6 12 and 24 months follow-up"
        }, 
        "source": "University Medical Centre Ljubljana", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "University of Ljubljana School of Medicine,  Slovenia", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Medical University of Vienna", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Harvard University", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University Medical Centre Ljubljana", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}